PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Articles

27-Aug-2010
An enterprising postgrad recently increased traffic to his very dry semiconductor physics website by posting naked shots of a young pop idol. But latest figures suggest pharmas don’t need Britney’s b
An enterprising postgrad recently increased traffic to his very dry semiconductor physics website by posting naked shots of a young pop idol. But latest figures suggest pharmas don’t need Britney’s boobs to grab men’s attention. They could try testicles… Men’s health related terms feature high up the hit lists of all the main search engines and it seems the ailing gentleman is now more likely to reach for his mouse than a bottle of Lucozade. The age of the informed patient is upon us and men in particular are increasingly switched on to the internet for health information. Traditionally…
Don’t take this as a come-on, but I think we could really benefit from getting up close and personal. Over the Internet. No, I’m not inviting you to enter into a dubious chat room dialogue, but to hav
Don’t take this as a come-on, but I think we could really benefit from getting up close and personal. Over the Internet. No, I’m not inviting you to enter into a dubious chat room dialogue, but to have a think about your company website. Personalisation has been an Internet buzzword since the end of the 90s when it was pioneered by book-seller Amazon amongst others. The online-trader’s ground-breaking take on the technology was to track clusters of titles purchased by the same individuals and then make recommendations to others users based on this knowledge. Amazon had a retail revolution on…
When setting up your online marketing plan ensure that search engine optimisation is not an afterthought to your banner ad spends. They are a primary means to drive traffic to your website and fairly
The increasingly untenable limitations placed on direct to consumer advertising of prescription drugs will doubtless soon be addressed by the powers that be, whether at national or European level and deregulation, when it happens will lead to an explosion in the number of product and therapy area websites being produced by the pharmaceutical industry. But in an online environment already crowded with millions of websites and little to no policing, how can marketing departments ensure that patients searching for the best cure for GORD ever stumble upon their experimental new drug megacurealot w…
EU Health.net is a development of the well-known Blackwell Masters health information database. It has been enhanced to provide information specifically on the activities of the NHS and a major additi
The trend towards healthcare planning in Europe is providing a level of visibility and market intelligence that was previously unavailable. EU Health.net is a development of the well-known Blackwell Masters health information database. It has been enhanced to provide information specifically on the activities of the NHS and a major addition is the insight into policies and initiatives occurring in the European healthcare arena. It covers a total of 120 categories (full list available on request) including cardiology & stroke, cancer, mental health, diabetes, HIV & sexual health, res…
The sampling process is repeated on a daily basis across the pharmaceutical industry with billions of dollars expended each year.
In the year 2000, US pharmaceutical companies spent 16 billion dollars supporting the distribution and marketing of prescription drug samples to physicians. A full 50% of those costs went directly to communicating the value of the products and another 26% went to the detailing, distribution, and management of the samples. Over the course of a typical month, the average pharmaceutical sales representative will visit 150 physicians, distribute thousands of packages of drug samples, obtain FDA required signatures on 150 sample distribution forms, receive scores of new sample cartons to their home-based office, and expend as much as 25% of their time tediously man…
In turbulent economic times, the need to streamline businesses and control costs is always of paramount importance. This is true whether your strategic mission is to be a low-cost producer or an inno
In turbulent economic times, the need to streamline businesses and control costs is always of paramount importance. This is true whether your strategic mission is to be a low-cost producer or an innovator in your industry. Top executives have often turned to Supply Chain Management in an attempt to achieve these goals. But how do you get past the rhetoric of Supply Chain Management theory that so often is populated with clichés and little real-world action? The solution is not to focus simply on the theory or tactics of Supply Chain Management. These are well known. Rather, we must als…
The race is on, but while some companies try to get it right first time, others are just trying everything while mistakes are still an option. The difficulties lie in the choice: today there are sever
The race to effective e-business solutions is on. Case studies of successes and failures are multiplying E-business conferences for the pharma industry are proliferating and shifting from being about theoretical benefits to dealing with real case study, an example of how the market has matured in the past year. A Cap Gemini Ernst and Young/Insead survey published in May 2001 estimates that the Industry has invested between 0.5% and 1% of sales (approximately $2 billion) on e-business over the past year, with mixed results. The majority of respondents (70%) agree that the biggest impact will…
The pharmaceutical industry, like many others is guilty of being too forgiving of email’s shortcomings. We would never accept misdirection or non-delivery of a package delivered by a courier so why so
With ever mounting competition it is becoming increasingly important for pharmaceutical companies to leverage new technologies as a means of gaining competitive advantage. Indeed, a recent study by Accenture Research in the US showed that eighty percent of the world’s leading pharmaceutical companies believed Internet-related technologies could not only speed up time to market, but also reduce drug development costs and administration. There is little doubt that email has been one of these key technologies. It has benefited a number of business processes across the industry, speeding up comm…
Statistics, properly audited and interpreted, allow you to establish hundreds of useful pieces of information about your customers after careful filtering from the enormous mass of information that is
It is a classic paradox of the new economy that a media that arose from the ground up offering free, democratic information access to all also provides companies and governments with an unparalleled opportunity to play at Big Brother. Putting aside these issues though, internet statistics are the single most vital aid to those responsible for websites. Statistics, properly audited and interpreted, allow you to establish hundreds of useful pieces of information about your customers after careful filtering from the enormous mass of information that is the logfile. The web is the ultimate weapon…
Some areas of the pharma industry are clearly at the cutting edge of new technology. But especially in Europe, this hasn't translated to eBusiness efforts in the sector - it's far behind other indust
Some areas of the pharma industry are clearly at the cutting edge of new technology. But especially in Europe, this hasn't translated to eBusiness efforts in the sector - it's far behind other industries in computerization and automation, particularly in Europe. So why are European pharma not capitalizing on the savings IT can bring, and when will this change? John Band investigates... What images does the pharmaceutical industry conjure up for you? Many people would see a hotbed of new technology. Perhaps a white-coated scientist, using the latest high-tech equipment to analyze the new drug…
E-business is turning from hype to reality and is starting to become that most crucial of things, measurable. Pharmaceutical companies must orient their businesses to take into account the formidable
A few years ago, the internet was booming and any idea or even word starting with "e" was seemingly worth millions. The new economy was here to stay.... Thousands of "start-ups" mushroomed. A year later, the bubble burst and "start-ups" began disappearing... Does that mean that the Internet won't deliver on its promises? Certainly not. But the reality is that the way to invest in the internet has changed. The gold rush has stopped. Pharmaceutical companies are moving away from the model where they outsourced work to pure dot.coms. Instead, they are moving toward a Clicks and Mortar model, wher…
27-Aug-2010
The pharma industry mega-merger is a gargantuan task that can make your working situation difficult or even untenable but if you approach the process objectively it can be turned to your advantage. He
The demands of investors and the paucity of promising drugs in the industry has led to a wave of big mergers and acquisitions in the last few years. As a result the industry landscape is full of monolithic companies with worldwide headcounts approaching those of cities. But despite all this action the largest pharmaceutical company in the world still only has a 7% market share and several of the major players still haven’t been involved in any consolidations, both Roche and MSD spring to mind. It’s therefore logical to assume that further consolidation will occur in the sector, consolidation t…
27-Aug-2010
The big change will come in the objectivity of the product web-sites that the pharmaceutical companies produce, or more accurately are forced to produce. Initially comprehensive first generation produ
Business has been living uneasily with the internet for several years now. Through the boom and bust of the first phase of the dot.com dream, through waves of non-event e-mail virus’ and promise after promise about how the internet can and will put millions on companies’ bottom line. As yet, the results have been minimal. If anything B2B, the dream of online procurement and improved efficiencies, has been even more of a disappointment than B2C. Most internet users have bought a CD or a book online but how many people do you know that have placed a stationary order that has been accepted online…
A lack of cohesive planning and poor execution has dogged the Internet and online ventures. After the initial frenzy surrounding any Internet-based idea, the pharmaceutical industry sat back and asses
Customisation is the key to m-health success A lack of cohesive planning and poor execution has dogged the Internet and online ventures. After the initial frenzy surrounding any Internet-based idea, the pharmaceutical industry sat back and assessed the situation, concluding that "e-anything" just does not work. This attitude could infect the mobile health, or m-health, arena. Hooman Bahmandeji, President, MedSphere Corp., USA, says it doesn't have to be that way. A little thought, combined with some in-depth research into what the user really wants, will reap its rewards. If the service is…
In this article, David explains some of the e-initiatives he and his team have launched at Novartis, describes the excitement from seeing first results and speaks about the challenges he is facing.
e-detailing? CRM? Wireless devices? B2B Marketplaces? e-supply chain? Online recruitment? e-clinical trials? All these terms are covered under the umbrella of e-Business. “e” today represents an array of new business opportunities for pharmaceutical companies to leverage their existing skills and customer relationships. But as attractive as e-propositions can look in concept, it is proving a major challenge to pharma industry executives to manage the way to the e-treasure. With the continuing uncertainty in the stock market environment for dot.coms, technology houses and telecomms, there is inte…
Finding the right people to send your application to can be a time consuming task, here, with the help of the ABPi we list the contact details for all the companies who are interested in hearing from
Personnel Manager Abbott Laboratories Abbott House Norden Road Maidenhead Berkshire SL6 4XE Tel: 01628 773355 Fax: 01628 644115 Online: www.abbott.com Personnel Manager Abbott Laboratories Queenborough Isle of Sheppey Kent ME11 5EL Tel: 01795 580099 Fax: 01795 593335 Online: www.abbott.com Recruitment Officer Amgen Limited 240 Cambridge Science Park Milton Road Cambridge CB4 4WD Tel: 01223 420305 Fax: 01223 426078 E-mail: uk-human-resources@uk.amgen.com Online: www.amgen.com Graduate Recruitment Officer General Recruitment AstraZeneca R&D at Charnwood Bakewell Road Loughborough Leiceste…
27-Aug-2010
Since the explosion of debate around the internet and e-commerce began questions have been asked about the future role of the pharmaceutical sales representatives. Here we take a broader look at the r
Whether you're an experienced rep or just thinking of what type of car you might get with the job, you can't have helped but notice that the language of those who work in healthcare, pharmaceuticals and medicine is one of war. Even where the action is not necessarily bloody disease is talked of as an enemy that must be identified, targeted and then destroyed. On the frontline between those who develop and those who deliver the arsenal of weapons in this war, are pharmaceutical reps. If disease is our enemy, drugs are our weapons, what does that make the rep? Supplies officers, or like NATO o…
In this feature, previously published in Pharmafield, Nicky Hickman looks at what developments in new technology will mean for the rep. With internet technology becoming smaller and more portable and
In parts of Asia-Pacific, mobile 'phones are known locally as 'handy's' and that's really the best way of thinking of the new generation of mobile 'phones, pocket-sized computers and other mobile devices. What's happened to the technology? Two strands of information and communications technology are merging in our pockets. The first is computer technology. If you've read the novel 'Stark' by Ben Elton, you'll remember the Japanese tycoon who turned a profit by making his consumer electronics products so small, everyone kept losing them and hence having to replace them. Until now there's bee…
Often descibed as 'the modern disease', stress is believed to be an underlying reason behind seven out of ten trips to GPs and in a recent survey it was claimed that an astonishing nine out of ten peo
Stress Often descibed as 'the modern disease', stress is believed to be an underlying reason behind seven out of ten trips to GPs and in a recent survey it was claimed that an astonishing nine out of ten people in full time work felt that they were under stress. But why should this be so? We live in an era of unprecedented wealth and opportunity where filely any whim that can be entertained can be achieved. Meanwhile modern medicine is capable of curing a huge amount of the ailments that plagued our ancestors, we no longer have to fear attack by woolly mammoth or even commitment to the poorhou…
Tobias Rooney, Principal at Cap Gemini Ernst & Young has specialised in the Life Sciences Unit R&D sector for the past five years. He looks at the current state of e-business in the Pharmaceutical ind
Could you introduce yourself? Tobias Rooney, Life Sciences Unit at Cap Gemini Ernst & Young. I have been doing management consultancy for the past seven years and I've specialised in the R&D sector for the past five. I have been involved in European and international projects for the major pharmaceutical companies. These projects have included strategic and operational missions for clients from middle management right up to the board. What types of e-projects are happening in the Life sciences area? At CGEY we have a segmentation of the market in three layers of e-business activities…